IART — INTEGRA LIFESCIENCES HOLDINGS CORP

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 917520 ·
Last close
$15.19
Market Cap
$1.18B
52W High
$15.45
52W Low
$8.70
ADV30
1,087,466
Next earnings
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 391,918,000 216,982,000 11,470,000 -4,617,000 3,577,726,000 236,809,000 2,535,320,000
Dec 2025 434,925,000 220,865,000 23,040,000 -1,704,000 3,602,001,000 235,048,000 2,558,538,000
Sep 2025 402,062,000 206,991,000 11,761,000 -5,404,000 3,646,452,000 232,186,000 2,608,878,000
Jun 2025 415,605,000 209,332,000 -1,309,000 -484,073,000 3,667,905,000 217,914,000 2,629,244,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$71,444,000
Investing CF
$-86,991,000
Financing CF
$1,255,000
CapEx
$-81,566,000
Dividends Paid
Buybacks
$-2,471,000
EPS Diluted TTM
$-6.46
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$418,824,000
Inventory
$495,035,000
Receivables
$264,413,000
ST Investments
$28,693,000
EBIT TTM
$-445,970,000
Pretax Income TTM
$-535,875,000
Interest Exp TTM
$89,905,000
Analysts
6

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,644,509,952
EBITDA
$308,296,992
Free Cash Flow
$69,289,752
Enterprise Value
$2,950,110,208
Total Cash
$265,502,000
Total Debt
$2,040,878,976
Shares Out
77,796,903
Trailing EPS
$-6.47
Book Value
$13.39
ROE
-38.6%
ROA
2.5%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 1,635,245,000 17,995,000 -516,474,000 3,602,001,000 2,558,538,000 50,384,000
Dec 2024 1,610,527,000 28,411,000 -6,944,000 4,037,424,000 2,492,144,000 129,382,000
Dec 2023 1,541,573,000 111,526,000 67,741,000 3,781,988,000 2,194,104,000 139,955,000
Dec 2022 1,557,666,000 238,920,000 180,550,000 3,889,758,000 2,085,355,000 264,469,000

TTM Snapshot

Revenues TTM
$1,535,307,000
NetIncome TTM
$101,946,000
OpCashFlow TTM
$0
Assets (Latest)
$4,037,424,000
Forward EPS
$2.61

Peers — same industry

TickerNameMarket CapLastDaily %
IRMD IRADIMED CORP $1.19B $92.94
BLFS BIOLIFE SOLUTIONS INC $1.17B $24.03
AVNS AVANOS MEDICAL, INC. $1.16B $24.75
INSP Inspire Medical Systems, Inc. $1.21B $41.99
ATEC Alphatec Holdings, Inc. $1.24B $8.06

News headlines (Yahoo Finance, 1h cache)

3 Inflated Stocks That Concern Us
2026-05-26 10:43 · Yahoo
3 Stocks Under $50 with Open Questions
2026-05-22 21:16 · Yahoo
Integra LifeSciences (IART) is a Top-Ranked Value Stock: Should You Buy?
2026-05-22 13:40 · Yahoo
A Look At Integra LifeSciences Holdings (IART) Valuation After Recent Share Price Momentum
2026-05-21 00:29 · Yahoo
IART or MASI: Which Is the Better Value Stock Right Now?
2026-05-18 15:40 · Yahoo
Why Integra LifeSciences (IART) is a Top Momentum Stock for the Long-Term
2026-05-18 13:50 · Yahoo
[Latest] Global Orthopedic Soft Tissue Repair Market Size/Share Worth USD 15.38 Billion by 2035 at a 9.6 CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation
2026-05-18 12:30 · Yahoo
Integra LifeSciences Says Transformation Is Working as SurgiMend Relaunch Nears
2026-05-17 22:02 · Yahoo
The Top 5 Analyst Questions From Integra LifeSciences’s Q1 Earnings Call
2026-05-15 05:08 · Yahoo
Integra LifeSciences (IART) Is Up 6.4% After Essig Returns As CEO With Reaffirmed 2026 Guidance
2026-05-14 17:17 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.